# Biohaven Pharmaceutical Holding Co Ltd. — Form D

Biohaven Pharmaceutical Holding Co Ltd. of New Haven, CT, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-10. The offering totals $80.0M, of which $40.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-11-10
- Form: D
- Accession: 0000908662-16-000598
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $40.0M
- Remaining: $40.0M
- Investors: 34
- Date of first sale: 2016-10-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-274252

## Issuer

- Name: Biohaven Pharmaceutical Holding Co Ltd.
- CIK: 0001689813
- Entity type: Other
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2013
- Address: 234 Church Street, Suite 304, New Haven, CT, 06510
- Phone: 203-404-0410

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Greg Bailey | Director | Gainesville, FL |
| John Childs | Director | NEW HAVEN, CT |
| Vladimir Coric, M.D. | Director | New Haven, CT |
| Declan Doogan | Director | Glasgow, X0 |
| Kam Shah | Director | New Haven, CT |
| Robert Berman, M.D. | Executive Officer | New Haven, CT |
| Vladimir Coric, M.D. | Executive Officer | New Haven, CT |
| Jim Engelhart | Executive Officer | New Haven, CT |
| Kimberly Gentile | Executive Officer | New Haven, CT |
| John Tilton | Executive Officer | New Haven, CT |

## More

- [CIK 1689813 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1689813&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000908662-16-000598.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.